Modified GRF (1-29) Peptide 2mg Vial – GHRH Research Peptide

What Is Modified GRF (1-29)?

Modified GRF (1-29), also known as a refined GHRH analog, is a synthetic peptide widely used in growth hormone research. Designed for improved stability, it mimics natural growth hormone-releasing hormone while offering more consistent performance in laboratory settings.

Numer CAS	863288-34-0
Inne nazwy	Modified GRF (1-29), Tetrasubstituted GRF (1-29),
Nazwa IUPAC	N/D
Wzór cząsteczkowy	C₁₅₂H₂₅₂N₄₄O₄₂
Masa cząsteczkowa	3367.95
Czystość	≥99% Pure (LC-MS)
Dostępność płynności	N/D
Dostępność proszku	2 milligrams (lyophilized/freeze-dried)
Warunki przechowywania	Przechowywać w chłodnym miejscu, trzymać w lodówce. Nie zamrażać.
Warunki	Wszystkie produkty są przeznaczone wyłącznie do badań laboratoryjnych i rozwojowych. Produkty nie są przeznaczone do spożycia przez ludzi.

---

How It Works

Growth Hormone Signaling Support

This peptide binds to GHRH receptors in the pituitary gland, helping researchers study pulsatile growth hormone release—a key factor in understanding endocrine balance and metabolic processes.

---

Why Choose a 2mg Vial?

Precision & Flexibility

The 2mg lyophilized format allows:

• Accurate measurement

• Controlled dosing in experiments

• Reliable storage and handling

Researchers often value its predictable response and stability, making it a dependable tool in peptide studies.

---

Storage Guidelines

• Store in a cool, dry place

• Refrigerate at 2–8°C after reconstitution

• Avoid repeated freeze–thaw cycles

---

Często zadawane pytania

What is Modified GRF (1-29) used for?

It is used in research involving growth hormone release and endocrine signaling.

How is it different from CJC-1295 with DAC?

It has a shorter action, allowing more natural hormone release patterns.

Is it for human use?

No, it is strictly for laboratory research purposes only.